Native vitamin D in pre-dialysis chronic kidney disease

Abstract

Chronic kidney disease patients have a high prevalence of vitamin D insufficiency/deficiency. Vitamin D deficiency has been associated with a variety of bone, metabolic and cardiovascular disorders. However, the role of native vitamin D supplementation (ergocalciferol, cholecalciferol or calcifediol) remains unclear in chronic kidney disease (CKD), particularly in the pre-dialytic phase. Several international guidelines have been developed on CKD-Mineral and Bone Disorder, but the optimal strategy for native vitamin D supplementation and its clinical benefit remains a subject of debate in the scientific community. This paper aims to review the available literature, including randomized clinical trials that evaluated the effects of native vitamin D supplementation on pre-dialysis CKD on biochemical and clinically relevant outcomes.

Keywords: Calcifediol; Cholecalciferol; Chronic renal disease; Colecalciferol; Enfermedad renal crónica; Ergocalciferol; Hiperparatiroidismo secundario; Native vitamin D; Secondary hyperparathyroidism; Vitamina D nativa.